Date post: | 17-Dec-2015 |
Category: |
Documents |
Upload: | tamsyn-hamilton |
View: | 217 times |
Download: | 0 times |
SRI SRIDHAR, Ph.D.
NCI/NSF NANOMEDICINE SCIENCE AND TECHNOLOGYELECTRONIC MATERIALS RESEARCH INSTITUTE
PHYSICS DEPARTMENTNORTHEASTERN UNIVERSITY
SUPPORTED BY NSF/NCI and AFRL
Collaborators:Dattatri NageshaEvin GultepeMansoor Amiji, Pharma Sciences Robert Campbell, Pharm SciVladimir Torchilin, Pharma Sciences Charles DiMarzio, ECE Latika Menon, Physics Alain Karma, PhysicsDon O’Malley, BiologyCarol Warner, Biology Ahmed Busnaina, MIE Shashi Murthy, Chemical EngineeringLaura Lewis, Chem Engg Nikos Soukos, Forsyth Dental InstituteMike Makrigiorgos & Robert Cormack, BWH-DFCI
NANOMEDICINE RESEARCH PLAN
Therapy
Diagnosis
Nanoparticle Platforms
Delivery
Sensing
Imaging
Control
Harvesting
DNA
Drugs
Hyperthermia
Magnetic
Electronic
Intra-cellular tracking
In Vivo imaging
Proteomics
Metal NP
Micelles
Nanoassemblies
Polymeric NP
Liposomes
FunctionMethods and Phenomena Disease
Cancer
Infectious Diseases
Cardio-vascular Diseases
Sickle Cell Disease
Embryonic Stem Cell
Multi-functional Nanoplatforms
PEGSpacer
TAT
Y
pH-SensitiveFluorescentLabel
Radioactive Label
Antibody EndosomeBufferingAgent
HIV TATPeptide
pDNA orOligonucleotide
Magnetic core
Au or Fe-Au NP1-100nm
Micelles10-50nm
Liposomes100-250 nm
Polymeric NP~ 20nm – 10 m
40 nm 30 nm40 nm40 nm40 nm 30 nm30 nm30 nm
TITANIA AND ALUMINA NANOTEMPLATES
SENSING, TARGETING, DELIVERY
SENSING, DRUG ELUTING PLATFORMS, SCAFFOLDS AND
TEMPLATES, NEUROCHIP
Y
Y
Y
Y
Fe
Au orFe-Au
Au + PEGAu + PEG +Fluorescent label
Au + PEG +LM609 Antibody
TARGETINGMRI CONTRAST ENHANCEMENTMICROWAVE HYPERTHERMIAGENE DELIVERY
Y
Y
Y
Y
Intracellular experimentsCellular Trafficking
Au + PEG +LM609 Antibody + pDNA
MULTI FUNCTIONAL NANOPARTICLES
OH-PEG-OHAg2O, KI
CH2Cl2, 0oC, 30 min
HO-PEG-OTs
Scheme 1
n = 1.5 K
'desymmetrization'
S Me,
O
K+ -
TsCl (10 equiv.)
pyr, 60oC
NaOMe / MeOHthen, Dowex DR 2030
OO
Me
NH
(95%)
MeOH, reflux, 48 hr
TsO-PEG-OTs
(96%)
(90%)
O-PEG-S Me
OO
OO
Me
NH
O-PEG-SH
O
HO-PEG-S Me
O
coumarin-isocyanatetoluene, reflux(85%)
(76%)
Au NANOPARTICLES WITH HETERO-BIFUNCTIONAL PEG FOR BIOMEDICAL APPLICATIONSWei Fu, Dinesh Shenoy, Curtis Crasto, Matt Bouchard, Jane Liu
Mansoor Amiji, Graham Jones, Sanjeev Mukerjee, Charles di Marzio, Sri Sridhar
AuAu + PEG
Au + PEG +Fluorescent label
Intracellular experimentsCellular Trafficking
Int. J. Nanomedicine (2005), Bioorganic & Medicinal Chemistry Letters (2005)
Nucleus
MultifunctionalNanoparticle
Protein
Release
mRNA
Early Endosome
Cell Membrane
Protein Expression
Nuclear Uptake
EndocytosisNon-SpecificUptake
TAT-MediatedUptake
Receptor-MediatedUptake
Free DNA
LIFE-CYCLE OF A NANOPARTICLE VECTOR
Mechanisms and PathwaysBinding
EndocytosisEndosomal Escape
Cytosolic TransportDegradation
Nuclear UptakeTransfection
Protein ExpressionMagnetic control with MagNP
2-Photon Luminescence – Gold nanoparticles in Mouse Embryonic Stem Cells
Int. J. of Nanomedicine (2007)
Gold nanoparticles when excited by a 2-photon femto second laser source, exhibits photoluminescence
Photoluminescence of 20 l gold NPs dried on glass slide
Collaboration: Dr. Charles Dimarzio and Dr. Gary Laevsky (ECE)Paula Lampton, Carol Warner (Biology), Int. J. Nanomedicine (2007)
Figure 3.
Imaging without a fluorophore
Texas Red (568nm) Alexa 488 conj. to FNG Au (760nm) from FNG
20X lens
IMAGING OF LARVAL ZEBRAFISH USING MULTI-PHOTON LUMINESCENCE OF Au NANOPARTICLESFluor-gold nanoparticles and Texas RedFluorophores for validation of technique (IGERT project)
Collaboration with Sucharita Saha, Don O’Malley, Chuck DiMarzio
New technique for studying gene delivery for spinal cord regeneration
Brightfield Scale Bar 100µm
Two Photon λ=750nm
Confocal Reflectance λ=920nm
Second Harmonic λ=920nm
Ag NANOPARTICLES IN ANIMAL SKIN With Yogesh Patel, Chuck DiMarzio
z-stack of excised skin sample recording an image every 3µm from the surface down 30µm
MOVIE
15µm below glass coverslip
21µm below glass coverslip
Confocal ReflectanceTwo-PhotonSecond-Harmonic
MAGNETIC NANOPLATFORMS
A variety of applications• Separation Science: cells, biomarkers,
harvesting • MRI contrast enhancement• Localized energy delivery –
hyperthermia, ablation• Magnetic Manipulation- magnetic
targeting, magnetic tweezers• Magnetic biosensors
SPION in hexane at 100 Oe
0.E+00
5.E-06
1.E-05
2.E-05
2.E-05
3.E-05
3.E-05
4.E-05
4.E-05
0 50 100 150 200 250 300 350T (K)
M (
emu
/ul)
ZFC
FCBlocking
temperature (TB) of
SPIONs
M vs B
-4.E-05
-3.E-05
-2.E-05
-1.E-05
0.E+00
1.E-05
2.E-05
3.E-05
4.E-05
-0.5 -0.3 -0.1 0.1 0.3 0.5
B (T)
M (em
u/uL)
hexane
micelle
SuperparamagnetismNo hysteresis in M-H curves
SuperParamagnetic Iron Oxide Nanoparticles (SPIONS)
Surface Modification Techniques for Magnetic Nanoparticles
-
- ----------
---
-
---
Iron oxide nanoparticles
+vely chargedpolyelectrolyte
+
+vely charged Iron oxide nanoparticles
+++ +
++
+ ++
+
a) Surface coating of magnetic NPs for direct attachment to cells
Cell membrane is –vely charged and will bind to +vely charged particles through electrostatics.
OH + EtO-Si-(CH2)3-R
OEt
OEt
O -Si-(CH2)3-R
OH
OH
R
R
R
R
R = NH2, SH, CHO
b) Attachment of molecules for conjugation of antibodies
Antibodies are conjugated through the R- functional group
c) Gold coating to form core-shell morphology
Iterative addition
HAuCl4 +Hydroxylamine
Gold surface can be readily conjugated with various biomolecules
Iron oxide NPs Iron oxide-goldCore-shell NPs
MAGNETIC NANOPARTICLES FOR MRI CONTRAST ENHANCEMENT
TEM image shows encapsulation of iron oxide NPs in the core of the micelle
SPION Encapsulated PEG-PE Micelle System
2C5-Iron oxide NP-Micelles incubated with BT20 cells.Nuclei stained with Hoechst (blue) and 2C5-Iron oxide NP-Micelle stained with Rhodamine B (Red).
Nanosized Cancer Cell-Targeted Polymeric Immunomicelles Loaded withSuperparamagnetic Iron Oxide NanoparticlesRishikesh M. Sawant a, Rupa R. Sawant a, Evin Gultepe b, Dattatri Nagesha b, BrigittePapahadjopoulos-Sternberg c, Srinivas Sridhar b, Vladimir P. Torchilin a
MULTI-MODAL USE OF MAGNPIMAGE GUIDED MAGNETO THERAPY
• MRI CONTRAST ENHANCEMENT
• MAGNETIC TARGETING– MAGC LIPOSOMES : CAMPBELL
collaboration– SPION-IMMUNOMICELLES :
TORCHILIN colaboration• MAGNETIC HYPERTHERMIA
NOVEL NANOPARTICLE APPROACHES TO MRI• NEW NANOPARTICLES, eg. Mn-Fe-O• MIX T1 AND T2 AGENTS• EXPLOIT NEW PULSE SEQUENCES FOR DIFFERENT TIME SCALES
• BOUND VS. FREE NANOPARTICLES
SPION-Micelles
SPION
SPIONs encapsulated in micelle specific anti-body attached SPION-
Micelle packages
intra-cellular experimentsin vivo studies
NMR studies
• Targeting
• MRI Contrast Agents
• Magnetic Hyperthermia
5 50Diameter (nm)
5 50Diameter (nm)
mPEG2000-DSPE Iron oxide NPs
Lipid film hydration
Sonication
Encapsulation in micelles system
-100000
-50000
0
50000
100000
-2.00E+06 0.00E+00 2.00E+06
Iron oxide NPs
Iron oxide NPsPEG-PE micelle
T = 260K
H (A/m)
M(A
/m)
SQUID Magnetization Measurement
With Sawant, Torchilin
TEM image shows encapsulation of iron oxide NPs in the core of the micelle
SPION Encapsulated PEG-PE Micelle System
2C5-Iron oxide NP-Micelles incubated with BT20 cells.Nuclei stained with Hoechst (blue) and 2C5-Iron oxide NP-Micelle stained with Rhodamine B (Red).
+NH2
Aqueous buffer
pH 8-8.5, 4˚C
Tumor-cell specific antinuclear antibody 2C5 was attached onto surface of SPION-
micelles via para-nitrophenyl-PEG-PE
mAb2C5 SPION-micelles
RHODAMINE filter
Bovine IgG SPION-micelles-
Bare SPION-micelles
HOECHST filter
Rhodamine-labeled-SPION-micelles were incubated with human breast tumor
MCF-7 cells in vitro. Associated fluorescence was observed using epifluorescence
microscopy.
Anti-body conjugation
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
4.00
Flu
ores
cen
ce a
t 55
0/59
0 n
m“Plain” SPION-micelles
mAb2C5 SPION-micelles
Bovine IgG SPION-micelles
0.35 mM PEG-PE 0.70 mM of PEG-PE0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
4.00
Flu
ores
cen
ce a
t 55
0/59
0 n
m“Plain” SPION-micelles
mAb2C5 SPION-micelles
Bovine IgG SPION-micelles
“Plain” SPION-micelles
mAb2C5 SPION-micelles
Bovine IgG SPION-micelles
0.35 mM PEG-PE 0.70 mM of PEG-PE
Associated rhodamine fluorescence was also quantified using fluorescence spectroscopy.
Fluorescence spectroscopy
Guided Drug DeliverySolid tumor
Apply magnetic field to concentrate particles
Modulate field to release drug from particles
Inject NMPs IV,NMP will circulate through the blood stream
Other options for targeting:1 - Direct injection into tumor site2 - Coating NMP with antibodies to target tumor
Magnetic Targeting
Iron oxide NPs encapsulated PEG-PE micelle systemShow significant R2 enhancement
Torchilin, Sawant (Pharmaceutical Sciences ), Kautz (Barnett)
NMR of Iron oxide NPs PEG-PE micelle
0
0.04
0.08
0.12
0.16
0.2
0 0.025 0.05 0.075 0.1 0.125 0.15
Concentration of iron oxide NPs (mg/mL)
1/T2
(sec
-1)
Iron oxide NPs
Iron oxide NPs-micelles Animal MRI
studies are ongoing at MGH
Relaxivity R2 (1/T2) signal associated with MCF-7 cells was measured using Varian INOVA 500MHz NMR Spectrometer.
Tumor-cell-specific-2C5-SPION micelles interact better and thus deliver more signal to the human breast tumor MCF-7 cells compared to the “plain” or non-specific IgG-SPION micelles.
R2 enhancement validated in in vitro cell studies
Animal MRI studies are
ongoing at MGH
mAb2C5-SPION-micelle
• SPION-micelle retains all the magnetic properties of the nanoparticles
• Magnetic targeting leads to 2x increase in tumor accumulation
• R2 relaxation significantly increased, leading to potential MRI contrast enhancement advantages
MAGNETIC CATIONIC LIPOSOMES FOR MRI AND HYPERTHERMIA
With Robert Campbell (NU)
Key advantages of MagC• Targets tumor vasculature• Very high cargo loading of nanocarrier• Can be combined with drugs, genes, etc
Healthy Mouse 1hr After Injection (H2)
Healthy Mouse 24hr After Injection (H1)
1hr after: the kidneys are dark because of the accumulation of iron oxide.
24hr after: kidneys are clear
Healthy Mouse (H2)
Tumor Mouse 24hr After Injection (T1)
Tumor Mouse 24hr After Injection + Magnet for 1hr (T2)
Heavily T2 weighted images
Angiography Pre-Injection Angiography Post-Injection
Arteries are invisible in post-injection images because of the circulating iron oxide.
Conclusion
• No animal death because of the injection• The concentration used is enough for the
contrast• Immediately after injection iron-oxides
circulate in the blood for at least one hour• 24hr after injection the kidneys are cleared• 1hr magnet placement has a positive
effect on the accumulation in the tumor even after 24 hours.
Magnetic nanoparticles heating up due to the oscillating magnetic field.
Gram-positive bacterium, E. faecalis, is exposed to ac magnetic field after incubating with nanoparticles for 5 minutes.
% killing vs exposure time
MAGNETIC HYPERTHERMIA FOR CANCER AND INFECTIOUS DISEASES
With Nikos Soukos, Forsyth Dental
100% kill achieved in 5-10 minsPromising results, further studies needed to assess clinical potentialPotential application to Biofilm disruption
Killing seems to be non-thermalMechanism needs to be understood
LOCALIZED ENERGY DELIVERY
EM induced drug release from liposomesWith Campbell, Torchilin
Cancer Hyperthermia and Thermal Ablation
BIOMOLECULAR CONTROLManipulating genetic structure by localized energy delivery
EM Microbicide
EM induced cell membrane disruption, eg. hemolysis
40 nm 30 nm40 nm40 nm40 nm 30 nm30 nm30 nm
Cross section SEM images of Titania nanohole arrays. The average height of thefilm is ~ 250nm and pore diameter 25-35nm.
Nanoporous Titania and Alumina Arrays Nanoassembly, Drug delivery Applications
Nanobead Assembly
More than 85% coverage over
1cm2 area.
• 50nm beads• 80nm nanoholes• 10V, electrophoresis• plate counter electrode.
Applied Physics Letters (2007)
Carbon Nanotube Assembly
SEM micrographs of assembled SWCNTs in anodic alumina array.
Applications:BiosensorsHigh Density Memory
Elution from Nanotemplates
www.csmc.edu
Example: Drug eluting stents
T. C. Woods, A. R. Marks Ann. Rev. Med., 55, 2004
Coronary artery stenosis
Balloon angioplasty
Stent Implantation
Drug eluting stent bare stent
Patent artery Restenosis
Elution from Nanotemplates
Concentration of the drug is measured in the release medium over the time.
A model drug, Doxorubicin, is loaded into alumina nanotemplates to observe release kinetics from a porous medium.
excitation wavelength
in-situ measurement
532 nm spectrometer
Anodic Alumina Nanoholes
Pore diameter: 190nm Pore thickness: 10um
Templates after loading with DOX.E: empty template
Titania NanotubesPore diameter: 125nm Pore thickness: 2.5um
Drug Elution from Nanotemplates
t<10min, best fit is a power. C(t) ∝ t1/2 ⇛ Fickian diffusion
t>10min, best fit is logarithmic. C(t) ∝ log(t) ⇛ CC(t)/ e dt
dC(t)
t1/2
log(t)
www.igert.neu.edu
A NEW INTERDISCIPLINARY IGERT PH.D. PROGRAM FUNDED BY THE
NATIONAL CANCER INSTITUTEAND NATIONAL SCIENCE FOUNDATION
$3.3M 2005-2010
PI & Dir: Professor Sri SridharMansoor Amiji, Sanjeev Mukerjee, Mary Jo Ondrechen, Gilda Barabino, Ph.D.
A NEW MODEL FOR GRADUATE EDUCATIONDRIVEN BY REAL WORLD RESEARCH PROBLEMS
Approaches and methods
ReportsPublicationsPresentationsResearch IntegrityEthics of Nanomedicine
Applications of Nanosystems in MedicineNanosystems at Biological InterfacesScientific Skills, Ethics, and CommercializationNanomedical Technology Seminar
Introduction to Nanomedical TechnologyNanosystems Design for Biomedical Applications
CommercializationProduct development Patent writingIntellectual propertyCultural diversityInternational outlook
•NP Preparation & functionalization•Electromagnetic energy delivery•Magnetic Nanoparticles for sensing and bio-control
•Cellular trafficking and modeling•Mitochondrial gene therapy• Cellular Bio-sensing
Industrial and international internships
Multi-disciplinary courses
Education and training
Communication Skills and Professional Conduct
Inter-disciplinary research groups
Interdisciplinary graduate Interdisciplinary graduate education, research, and education, research, and
training at the interface of training at the interface of nanotechnology, biotechnology nanotechnology, biotechnology
and medicineand medicine
Vision
IGERT Nanomedicine Science and Technology
Timeline and Requirements
Year 1 Year 2 Year 3 Year 4 Year 5
Subtitle
10/14/2004
Fellows Participating inCoursework and Seminars
Admission ofIGERT Fellows
Active Industrial Participation Including Internship,Serving on Advisory Committee, and Mentorship
Year 2Qualifying Exams
Subtitle
10/14/2004NanomedicineDissertation Research
Year 5Thesis Defenseand Graduation
PhD inNanomedtech
Year 1 Year 2 Year 3 Year 4 Year 5
Subtitle
10/14/2004
Fellows Participating inCoursework and Seminars
Admission ofIGERT FellowsAdmission ofIGERT Fellows
Active Industrial Participation Including Internship,Serving on Advisory Committee, and Mentorship
Year 2Qualifying Exams
Subtitle
10/14/2004NanomedicineDissertation Research
Year 5Thesis Defenseand Graduation
PhD inNanomedtech
OUTREACH K-12 Coordinated by Claire Duggan (www.ret.neu.edu)
HOSPITAL / INDUSTRY INTERNSHIPCo-mentoring by a scientist outside NU
Admission to home department
Ph.D. in core discipline with specialization in Nanomedicine
New Nanomedicine courses (12 Semester Hours)
IGERT FUNDING
New Nanomedicine coursesFirst of its kind
1. Nanomedicine Science and Technology Seminar (Jan 2006)
2. Intro to Nanomedicine S&T ( started Fall 2006)3. Nanosystems Design for Biomedical
Applications (started Spring 2007)
Guest lecturers from Mass Gen, Dana Farber, Beth Israel, Advance Nanotech, …
IGERT NANOMEDICINEBouve College
of Health SciencesCollege of Artsand Sciences
College of Engineering
BiologyPaula LamptonAdvisor: Carol Warner
Anthony D’OnofrioAdvisor: Kim Lewis
Sucharita SahaAdvisor: Don O’Malley
ChemistryHeather BroadkinAdvisor: Mary Jo Ondrechen
Adam HendricksAdvisor: Robert Hanson
Tatyana ChernenkoAdvisor: Max Diem
Electrical and Computer EngineeringYogesh Patel Advisor: Charles DiMarzio
Mechanical and Industrial EngineeringRobert CampAdvisor: Jeff Ruberti
Chemical EngineeringSavidra LucateroAdvisor: Rebecca Carrier
Pharmaceutical SciencesLilian van VlerkenAdvisor: Mansoor Amiji
Mattia MiglioreAdvisor: Barbara Waszczak
Lara JabrAdvisor: Volkmar Weissig
Luis BritoAdvisor: Mansoor Amiji
Padmaja MagadalaAdvisor: Mansoor Amiji
Lilian van VlerkenModulation of Intracellular Ceramide
using Polymeric Nanoparticles to Overcome Multidrug Resistance (MDR) of Breast Cancer
Advisor: Dr. Mansoor M. Amiji
Mattia M. Migliore Advisor: Dr. Barbara Waszczak
Intranasal delivery of GDNF using nanoparticle technology for the treatment of Parkinson’s disease
occurance of apoptosis in MDR breast cancer cells, previously resistant to cell death, with experimental therapy
Substantia nigra dopamine neurons ( 40x view) of a rat that was administered cationic liposomes loaded with Alexa-488 ovalbumin intranasally and sacrificed after 24hrs
IGERT NANOMEDICINE + PHARMA SCI
Padmaja MagadalaDepartment: Pharmaceutical Sciences
Advisor: Mansoor Amiji
"HER2/neu Receptor-Targeted Gelatin-Based Nanovectors for Pancreatic Cancer Gene Therapy"
C)
Blank Gel NPs Unmodified Gel NPs
PEG-Gel NPs Pep-PEG-Gel NPs
Quantitative and qualitative tranfection efficiency study of control and modified gel-NPs in panc-1 cells by FACS (A), ELISA (B) and fluorescence microscopy (C)
Paula LamptonAdvisor: Dr.Carol WarnerDepartment of Biology
Nanoparticles for analysis of
immune system molecules in
mouse embryonic stem cells
IGERT NANOMEDICINE + BIOLOGY
Sucharita Saha
Advisor: Donald O'Malley
Visualization and Enhancement of Spinal Cord Regeneration using Nanoparticles
Application of Nanoarray Technologies to Spinal Stimulation and Regeneration: the Nano-BMI (brain-machine interface)
See poster at this meeting
IGERT K-12 outreach• Research Experiences for Teachers (RET)• Young Scholars Program• Lesson Development• Field Trips/Presentations• Science Fair Mentoring and Support
www.igert.neu.edu